Cargando…

Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy

INTRODUCTION: Diabetic retinopathy is a leading cause of blindness in adults of working age. Patients with sight-threatening diabetic retinopathy (STDR) often have poor control of modifiable risk factors, including blood pressure and blood glucose. Patients in our eye department with STDR whose diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamtora, Sunil, Sandinha, Teresa, Carey, Peter E., Steel, David H. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449289/
https://www.ncbi.nlm.nih.gov/pubmed/27858333
http://dx.doi.org/10.1007/s40123-016-0069-z
_version_ 1783239738886455296
author Mamtora, Sunil
Sandinha, Teresa
Carey, Peter E.
Steel, David H. W.
author_facet Mamtora, Sunil
Sandinha, Teresa
Carey, Peter E.
Steel, David H. W.
author_sort Mamtora, Sunil
collection PubMed
description INTRODUCTION: Diabetic retinopathy is a leading cause of blindness in adults of working age. Patients with sight-threatening diabetic retinopathy (STDR) often have poor control of modifiable risk factors, including blood pressure and blood glucose. Patients in our eye department with STDR whose diabetes was managed only by their general practitioner (GP) were referred to a diabetes specialist. We have reviewed these referrals and assessed the control of modifiable risk factors in these patients at the time of referral. METHODS: A retrospective study was performed which identified 54 patients with STDR who had been referred from our eye department to a diabetes specialist between May 2013 and August 2014. Patient demographics, grades of retinopathy, glycated hemoglobin (HbA1c) levels, blood pressure, and lipid profiles were noted from the initial clinic visit and the first clinic appointment after 12 months. Initial management and any subsequent changes to management were recorded. RESULTS: Of the 54 patients initially referred to the dedicated diabetic retinopathy clinic, data from 32 patients were available for analysis; 22 patients failed to attend the clinic. The majority of patients who presented to the clinic were found to have inadequate control of modifiable risk factors. At the initial clinic visit, nine of the 32 (28%) patients had a blood pressure that was less than the target of 130/80 mmHg and only two (6%) had a HbA1c level of less than the target of 48 mmol/L for type 2 diabetes and 58 mmol/L for type 1 diabetes, respectively. Changes were made to the management in 24 (75%) of the patients. Blood pressure management was changed in 18 (56%) patients. Overall, changes were made to blood pressure management and lipid and glycemic medication, including insulin. CONCLUSION: The majority of patients with STDR were receiving suboptimal medical management. Collaboration between GPs, diabetes specialists, and ophthalmologists can lead to optimized medical management. All eye departments should develop protocols specifying when patients with diabetic retinopathy should be referred for to a diabetes specialist for input.
format Online
Article
Text
id pubmed-5449289
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-54492892017-06-15 Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy Mamtora, Sunil Sandinha, Teresa Carey, Peter E. Steel, David H. W. Ophthalmol Ther Original Research INTRODUCTION: Diabetic retinopathy is a leading cause of blindness in adults of working age. Patients with sight-threatening diabetic retinopathy (STDR) often have poor control of modifiable risk factors, including blood pressure and blood glucose. Patients in our eye department with STDR whose diabetes was managed only by their general practitioner (GP) were referred to a diabetes specialist. We have reviewed these referrals and assessed the control of modifiable risk factors in these patients at the time of referral. METHODS: A retrospective study was performed which identified 54 patients with STDR who had been referred from our eye department to a diabetes specialist between May 2013 and August 2014. Patient demographics, grades of retinopathy, glycated hemoglobin (HbA1c) levels, blood pressure, and lipid profiles were noted from the initial clinic visit and the first clinic appointment after 12 months. Initial management and any subsequent changes to management were recorded. RESULTS: Of the 54 patients initially referred to the dedicated diabetic retinopathy clinic, data from 32 patients were available for analysis; 22 patients failed to attend the clinic. The majority of patients who presented to the clinic were found to have inadequate control of modifiable risk factors. At the initial clinic visit, nine of the 32 (28%) patients had a blood pressure that was less than the target of 130/80 mmHg and only two (6%) had a HbA1c level of less than the target of 48 mmol/L for type 2 diabetes and 58 mmol/L for type 1 diabetes, respectively. Changes were made to the management in 24 (75%) of the patients. Blood pressure management was changed in 18 (56%) patients. Overall, changes were made to blood pressure management and lipid and glycemic medication, including insulin. CONCLUSION: The majority of patients with STDR were receiving suboptimal medical management. Collaboration between GPs, diabetes specialists, and ophthalmologists can lead to optimized medical management. All eye departments should develop protocols specifying when patients with diabetic retinopathy should be referred for to a diabetes specialist for input. Springer Healthcare 2016-11-17 2017-06 /pmc/articles/PMC5449289/ /pubmed/27858333 http://dx.doi.org/10.1007/s40123-016-0069-z Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Mamtora, Sunil
Sandinha, Teresa
Carey, Peter E.
Steel, David H. W.
Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title_full Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title_fullStr Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title_full_unstemmed Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title_short Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
title_sort optimizing medical management in patients with sight-threatening diabetic retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449289/
https://www.ncbi.nlm.nih.gov/pubmed/27858333
http://dx.doi.org/10.1007/s40123-016-0069-z
work_keys_str_mv AT mamtorasunil optimizingmedicalmanagementinpatientswithsightthreateningdiabeticretinopathy
AT sandinhateresa optimizingmedicalmanagementinpatientswithsightthreateningdiabeticretinopathy
AT careypetere optimizingmedicalmanagementinpatientswithsightthreateningdiabeticretinopathy
AT steeldavidhw optimizingmedicalmanagementinpatientswithsightthreateningdiabeticretinopathy